← FDA Drug Approvals (Drugs@FDA)

EVOMELA

NDA · New Drug Application · Sponsor: ACROTECH BIOPHARMA · Approved 2016-03-10

Drug application

FDA Application #

NDA207155

Application type

New Drug Application

Brand name

EVOMELA

Generic name

MELPHALAN

Active ingredients

MELPHALAN HYDROCHLORIDE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ACROTECH BIOPHARMA

Manufacturer

Acrotech Biopharma Inc

First approval

2016-03-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown